SLC5A5 and neoplasm: The limitation of using NIS-mediated radioactivity uptake as a metabolic response biomarker is that NIS is expressed only in a subset of non-malignant mammalian tissue types, including stomach epithelium, thyroid and lactating mammary glands [9, 13], which necessitates the modification of the investigated tumour models to express NIS.